Correction: Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry - Summary - MDSpire

Correction: Type 1 and type 2 NSTEMI in atrial fibrillation: insights from the HERA-FIB registry

  • By

  • Mustafa Yildirim

  • Christian Salbach

  • Johannes Dürr

  • Matthias Mueller-Hennessen

  • Hugo A. Katus

  • Norbert Frey

  • Evangelos Giannitsis

  • May 11, 2026

  • 0 min

Share

Objective:

To correct inaccuracies in the published article regarding predictors of composite endpoints and event-free survival in NSTEMI patients with atrial fibrillation.

Key Findings:
  • Prior MI hazard ratio corrected from 1.62 to 1.41.
  • Event-free survival p-value corrected from 0.0079 to 0.00989.
  • Clarified that bradycardia, not tachyarrhythmia, is a rate-related trigger for troponin elevations.
Interpretation:

The corrections enhance the accuracy of the findings related to NSTEMI in patients with atrial fibrillation, ensuring that the statistical analyses reflect true associations.

Limitations:
  • Corrections may affect the interpretation of previous findings.
  • Potential impact on clinical recommendations based on the original data.
Conclusion:

The original article has been corrected to provide accurate data on predictors and outcomes in NSTEMI patients with atrial fibrillation.

Original Source(s)

Related Content